Related Experiment Video
Updated: May 24, 2026
07:06
Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies
Published on: January 10, 2025
Platelet function and signaling in diabetes mellitus.
Voahanginirina Randriamboavonjy1, Ingrid Fleming
1Institute for Vascular Signalling, Centre for Molecular Medicine, Johann Wolfgang Goethe University, Theodor-Stern-Kai 7, D-60596 Frankfurt am Main, Germany. voahangy@vrc.uni-frankfurt.de
Current Vascular Pharmacology
|February 18, 2012
Summary
Diabetic platelets are hyperactivated, contributing to vascular disease and atherothrombosis through growth factor release and microRNA-carrying microparticles. This review explores their signaling pathways and role in disease progression.
Area of Science:
- Cardiovascular Biology
- Endocrinology
- Hematology
Background:
- Diabetes mellitus accelerates vascular disease.
- Platelets play a significant role in this accelerated vascular pathology.
- Platelet activation influences endothelial and smooth muscle cell function.
Purpose of the Study:
- To review intracellular signaling mechanisms of hyperactivated diabetic platelets.
- To elucidate the role of platelets in atherothrombosis development in diabetes.
Main Methods:
- Review of existing literature on platelet signaling in diabetes.
- Analysis of mechanisms of platelet-mediated vascular modulation.
- Examination of platelet involvement in atherothrombosis.
Main Results:
- Diabetic platelets exhibit increased activation.
- Platelets release growth factors and chemokines affecting vascular cells.
- Platelet-derived microparticles deliver microRNAs, modulating cellular function.
- Platelets are key contributors to atherothrombosis in diabetic patients.
Conclusions:
- Understanding diabetic platelet hyperactivation is crucial for managing vascular complications.
- Targeting platelet signaling pathways may offer therapeutic strategies for diabetic vascular disease.
- Platelets are central players in the pathogenesis of atherothrombosis in diabetes.
Related Concept Videos
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:18Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...